Efficacy of tricyclic drugs in treating child and adolescent depression: A Meta-analysis

BMJ

Volumn 310, Issue 6984, 1995, Pages 897-

  Hazell, P ^a   O'connell, D ^b   Heathcote, D ^a   Robertson, J ^b   Henry, D ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; IMIPRAMINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0028986262     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.310.6984.897     Document Type: Article

References (40)

1. Weller EB Weller RA. Mood disorders. In: LewisMed. Child and adolescent psychiatry. A comprehensive textbook. Baltimore: Williams and Wilkins, 1991: 646–64.
2. Rosenberg ML Eddy DM Wolpert RC Broumas EP. Developing strategies to prevent youth suicide. In: PfefferCRed. Suicide among youth: perspectives on risk and prevention. Washington, DC: American Psychiatric Press, 1989: 203–25.
3. Ambrosini PJ Bianchi MD Rabinovich H Elia J. Antidepressant treatments in children and adolescents. I. Affective disorders. J Am Acad Child Adolesc Psychiatry 1993; 32: 1–6.
4. Ambrosini PJ Bianchi MD Rabinovich H Elia J. Antidepressant treatments in children and adolescents. II. Anxiety, physical and behavioral disorders. J Am Acad Child Adolesc Psychiatry 1993; 32: 483–93.
5. Conners CK. Methodology of antidepressant drug trials for treating depression in adolescents. J Child Adolesc Psychopharmacol 1992; 2: 11–22.
6. Elliott GR. Dilemmas for clinicians and researchers using antidepressants to treat adolescents with depression. J Child Adolesc Psychopharmacol 2: 2: 7–9.
7. Jensen PS Ryan ND Prien R. Psychopharmacology of child and adolescent major depression: present status and future directions. J Child Adolesc Psychopharmacol 92: 2: 31–45.
8. Popper C. Are clinicians ahead of researchers in finding a treatment for adolescent depression? J Child Adolesc Psychopharmacol 1992; 2: 1–3.
9. Ryan ND. Heterocyclic antidepressants in children and adolescents. J Child Adolesc Psychopharmacol 1990; 1: 21–31.
10. Ryan ND. The pharmacologic treatment of child and adolescent depression. Psychiatr Clin North Am 1992; 15: 29–39.
11. Strober M. The pharmacotherapy of depressive illness in adolescence. III. Diagnostic and conceptual issues in studies of tricyclic antidepressants. J Child Adolesc Psychopharmacol 1992; 2: 23–9.
12. Taylor E. Commissioned review—Psychopharmacology in childhood. Newsletter of the Association for Child Psychology and Psychiatry 1988; 10: 2: 3–6.
13. Campbell M Spencer EK. Psychopharmacology in child and adolescent psychiatry: A review of the past five years. J Am Acad Child Adolesc Psychiatry 1988; 27: 269–79.
14. Beiderman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry 1991; 30: 495–8.
15. Riddle M Nelson JC Kleinman CS Rasmusson A Leckman JF King RA Cohen DJ. Case study: sudden death in children receiving Norpramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 1991; 30: 104–8.
16. Riddle M Geller B Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32: 792–7.
17. Geller B Fox LW Fletcher M. Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds. J Am Acad Child Adolesc Psychiatry 1993; 32: 43–50.
18. Akiskal HS Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68–73.
19. Sacks HS Berrier J Reitman D Ancona-Berk VA Chalmers TC. Meta-analysis of randomised controlled trials. N Engl J Med 1987; 316: 450–5.
20. Chalmers TC Smith H Blackburn B Silverman B Schroeder B Reitman D Ambroz A. A method for assessing the quality of a randomised control trial. Controlled Clin Trials 1981; 2: 31–49.
21. Petti T. Scales of potential use in the psychopharmacological treatment of depressed children and adolescents. Psychopharmacol Bull 1985; 21: 951–77.
22. Puig-Antich J Perel JM Lupatkin W Chambers WJ Tabrizi MA King J, et al. Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry 1987; 44: 81–9.
23. Kramer AD Feguine RJ. Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Psychiatry 1981; 20: 636–44.
24. Petti TA Law W. Imipramine treatment of depressed children: a double-blind pilot study. J Clin Psychopharmacol 1982; 2: 107–10.
25. Hedges LV Olkin I. Statistical methods for meta-analysis. San Diego: Academic Press, 1985.
26. DerSimonian R Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177–88.
27. Mehta C Patel N. StatXact. Statistical software for exact nonparametric inference. Version 2.0. Cambridge, MA: Cytel Software Corporation, 1991.
28. Berney T Kolvin I Bhate SR Garside RF Jeans J Kay B, et al. School phobia: a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry 1981; 138: 110–8.
29. Kashani JH Shekim WO Reid JC. Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study. J Am Acad Child Psychiatry 1984; 23: 348–51.
30. Preskorn SH Weller EB Weller RA. Depression in children: relationship between plasma imipramine levels and response. J Clin Psychiatry 1982; 43: 450–3.
31. Geller B Cooper TB McCombs HG Graham D Wells J. Double-blind, placebo-controlled study of nortriptyline in depressed children using a “fixed plasma level” design. Psychopharmacol Bull 1989; 25: 101–8.
32. Geller B Cooper TB Graham DL Fetner HH Marsteller FA Wells JM. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6–12 year-olds with major depressive disorder. J Am Acad Child Adolesc Psychiatry 1992; 31: 34–44.
33. Bernstein GA Garfinkel BD Borchardt CM. Comparative studies of pharmacotherapy for school refusal. J Am Acad Child Adolesc Psychiatry 1990; 29: 773–81.
34. Geller B Cooper TB Graham DL Marsteller FA Bryant DM. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a “fixed plasma level” design. Psychopharmacol Bull 1990; 26: 85–90.
35. Hughes CW Preskorn SH Weller E Weller RA Hassanein R Tucker S. The effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacol Bull 1990; 26: 235–8.
36. Boulos C Kutcher S Marton P Simeon J Ferguson B Roberts N. Response to desipramine treatment in adolescent major depression. Psychopharmacol Bull 1991; 27: 59–65.
37. Barber JP Luborsky LB. Psychotherapy research: issues to consider in planning a study. In: HsuLKGHersenMeds. Research in psychiatry. Issues, strategies and methods. New York: Plenum, 1992: 331–58.
38. Byrne MM. Meta-analysis of early phase II studies with paroxetine in hospitalised depressed patients. Acta Psychiatr Scand 1989; 80(suppl 350):138–9.
39. Sheldon T Mason J Song F Freemantle N House A. Effective and acceptable treatment for depression (letter). BMJ 1993; 306: 1126–7.
40. Fisher S Greenberg RP. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis 1993; 181: 345–50.